It's Tuesday, February 16th, welcome to Marketfoolery, I'm Chris Hale joining me today, Jason

Moser in the house.

Good to see you.

Addy, how are you?

I'm doing all right, we've got a bunch of things to get to, we've got auto sales, we've

got tech earnings, we're going to start with healthcare, fourth quarter profits for CVS

health came in higher than expected, foot traffic is down in the stores which is to be expected

but pharmacy sales are up, CVS is doing COVID-19 testing as well as vaccines, it seems like

this was a pretty solid quarter.

Yeah, you know, I mean, when you look at CVS, this hasn't been the greatest investment

over the past several years, I wonder though if we won't see going forward, perhaps

some goodwill and some brand equity come from all of this stuff that's coming with

the pandemic.

But because I think CVS ultimately is being seen as a part of the solution here, right?

I mean, they've, they've been selected as one of the national partners for the federal

pharmacy partnership program and that's ultimately what is behind the Biden administration's

plan to vaccinate 300 million Americans by the end of the summer, lofty gold, no doubt

about it.

But man, I think when it comes to something like that, you got to go big, right?

They've been, they've been a central part of the vaccines in regard to the long term

care homes.

And so I think all together, understanding the challenges that the company's seen over

...